Article Details
Retrieved on: 2022-08-28 19:24:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Analyst Upgrades and Downgrades. Separately, Morgan Stanley lowered their price objective on shares of Sana Biotechnology to $15.00 and set an “ ...
Article found on: www.etfdailynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here